Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00005609 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]